The long read sequencing market, valued at US$ 0.6 billion in 2023, is expected to grow to US$ 11.6 billion by 2034, driven by a CAGR of 30.96%. This growth is fueled by the rising prevalence of genetic disorders, advancements in R&D, and the increasing demand for personalized medicine.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5324
Long-read sequencing (LRS) is an advanced DNA sequencing technique that determines the nucleotide sequence of long DNA strands. Unlike short-read sequencing, which requires cutting and amplifying the DNA, LRS offers a more efficient and accurate way to sequence long stretches of DNA. This method can read tens to thousands of kilobases in length, making it especially valuable for detecting large-scale mutations, such as large deletions or rearrangements in the DNA.
The growing demand for genomics research, fueled by increasing cases of genetic and chromosomal disorders, is driving the long-read sequencing market. Advances in molecular biology are also pushing the boundaries of genetic variation studies, helping to uncover mutations behind human diseases. Additionally, the rising demand for personalized medicine is further accelerating the adoption of LRS technologies.
In October 2024, Azenta Inc. launched a long-read Whole Genome Sequencing (WGS) test for clinical use, becoming the first commercial provider in the US to gain regulatory approval for this service.
That same month, PacBio announced a partnership with the National Cancer Center of Singapore (NCCS) to use its cutting-edge sequencing technologies to advance cancer research and map the genomic landscape of common cancers in Asia.
In July 2024, Oxford Nanopore Technologies expanded its collaboration with Plasmidsaurus to revolutionize the plasmid sequencing market through innovative nanopore technology.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/long-read-sequencing-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5324
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global perfusion systems market was valued at USD 1.15 billion in 2023 and is projected to reach USD 1.94… Read More
The global in vitro diagnostics market is witnessing strong growth, with a projected market size of USD 123.45 billion by 2034,… Read More
Chinese biopharmaceutical innovator Mabwell has announced a major milestone in its oncology pipeline: its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911,… Read More
Global medical technology leader Demetra has announced the launch of its new spine-focused division, Demetra Spine, following its strategic acquisition… Read More
A groundbreaking multi-institutional study has uncovered a hidden mechanism potentially responsible for the high recurrence rate in ovarian cancer patients,… Read More
In a promising turn for brain cancer research, funding for glioblastoma (GBM) has seen a significant uptick, spurred by nonprofit… Read More